BFA
NVIV

BlackRock Fund Advisors’s InVivo Therapeutics Holdings Corp NVIV Stock Holding History

BlackRock Fund Advisors’s Portfolio NVIV Stock Details NVIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$4.31M Buy
55
+8
+17% +$715K ﹤0.01% 2992
2016
Q3 		$6.05M Buy
47
+3
+7% +$374K ﹤0.01% 2759
2016
Q2 		$4.79M Hold
44
– – ﹤0.01% 2837
2016
Q1 		$5.74M Buy
44
+6
+16% +$644K ﹤0.01% 2673
2015
Q4 		$5.16M Buy
38
+1
+3% +$149K ﹤0.01% 2828
2015
Q3 		$5.91M Hold
37
– – ﹤0.01% 2701
2015
Q2 		$11.3M Buy
+37
New +$9.78M ﹤0.01% 2431

Other funds holding NVIV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
WF
Welch & Forbes Boston, Massachusetts $7.73B AUM 14.94% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ICM
IMS Capital Management Portland, Oregon $217M AUM 18.69% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
GC
Guggenheim Capital Chicago, Illinois $12.9B AUM 27.3% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BlackRock Fund Advisors's NVIV Position: Q4 2016 in Review

BlackRock Fund Advisors increased its InVivo Therapeutics Holdings Corp (NVIV) stake by 17% in Q4 2016, buying an estimated $715K and bringing the position to 55 shares worth $4.31M. The position accounts for ﹤0.01% of the portfolio, ranked #2992.

BlackRock Fund Advisors first reported a position in NVIV in Q2 2015 and has held it in 7 quarters since. The position peaked at $11.3M in Q2 2015. 51 funds tracked by Wall St. Rank hold NVIV as of Q4 2016.

  • BlackRock Fund Advisors held 55 shares of InVivo Therapeutics Holdings Corp worth $4.31M as of Q4 2016.
  • BlackRock Fund Advisors bought 8 InVivo Therapeutics Holdings Corp shares in Q4 2016, an estimated $715K.
  • InVivo Therapeutics Holdings Corp made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #2992 holding.
  • BlackRock Fund Advisors first reported a position in InVivo Therapeutics Holdings Corp in Q2 2015 and has held it in 7 quarters since.
  • BlackRock Fund Advisors's InVivo Therapeutics Holdings Corp position peaked at $11.3M in Q2 2015.
  • 51 funds tracked by Wall St. Rank held InVivo Therapeutics Holdings Corp as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.